Jochen Maas

2.5k total citations · 1 hit paper
18 papers, 1.8k citations indexed

About

Jochen Maas is a scholar working on Pharmacology, Pediatrics, Perinatology and Child Health and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Jochen Maas has authored 18 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Pharmacology, 3 papers in Pediatrics, Perinatology and Child Health and 3 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Jochen Maas's work include Pharmacogenetics and Drug Metabolism (3 papers), Pharmaceutical studies and practices (3 papers) and Cardiac Arrhythmias and Treatments (2 papers). Jochen Maas is often cited by papers focused on Pharmacogenetics and Drug Metabolism (3 papers), Pharmaceutical studies and practices (3 papers) and Cardiac Arrhythmias and Treatments (2 papers). Jochen Maas collaborates with scholars based in Germany, France and South Africa. Jochen Maas's co-authors include Vito J. Palombella, Christine Pien, J I Johnson, Antonia T. Destree, Edward A. Sausville, Julian Adams, Peter J. Elliott, Douglas Lazarus, Dieter Mayer and Franz J. Hock and has published in prestigious journals such as SHILAP Revista de lepidopterología, Cardiovascular Research and Schizophrenia Bulletin.

In The Last Decade

Jochen Maas

18 papers receiving 1.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Proteasome inhibitors: a novel class of potent and effective antitumor agents.

1999 1.2k citations Julian Adams, Vito J. Palombella et al. PubMed profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jochen Maas Germany	12	1.1k	554	341	162	125	18	1.8k
Mamoru Shoji United States	30	1.8k 1.6×	493 0.9×	377 1.1×	360 2.2×	87 0.7×	63	3.0k
Roberta Frapolli Italy	27	1.0k 0.9×	647 1.2×	246 0.7×	297 1.8×	79 0.6×	85	2.3k
Yuan Zhou China	26	1.3k 1.2×	434 0.8×	267 0.8×	351 2.2×	143 1.1×	102	2.2k
Ján Sedlák Slovakia	24	919 0.8×	333 0.6×	141 0.4×	171 1.1×	57 0.5×	57	1.5k
Richard Hill United States	28	1.3k 1.2×	622 1.1×	326 1.0×	436 2.7×	181 1.4×	48	2.6k
H J Broxterman Netherlands	21	1.2k 1.1×	1.7k 3.1×	221 0.6×	214 1.3×	117 0.9×	27	2.4k
Tina Colombo Italy	25	737 0.7×	910 1.6×	130 0.4×	242 1.5×	76 0.6×	76	1.8k
Sherman F. Stinson United States	26	959 0.9×	629 1.1×	84 0.2×	273 1.7×	124 1.0×	57	2.2k
A. Leyva Netherlands	24	1.1k 1.0×	647 1.2×	159 0.5×	215 1.3×	144 1.2×	74	1.8k

Countries citing papers authored by Jochen Maas

Since Specialization

Citations

This map shows the geographic impact of Jochen Maas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jochen Maas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jochen Maas more than expected).

Fields of papers citing papers by Jochen Maas

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jochen Maas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jochen Maas. The network helps show where Jochen Maas may publish in the future.

Co-authorship network of co-authors of Jochen Maas

This figure shows the co-authorship network connecting the top 25 collaborators of Jochen Maas. A scholar is included among the top collaborators of Jochen Maas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jochen Maas. Jochen Maas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

Wieland, H. & Jochen Maas. (2024). Novel and Proven Models of Public, Private, and Public–Private Partnerships in Healthcare: An Update. Handbook of experimental pharmacology. 286. 1–19. 1 indexed citations

Niederberger, Ellen, Michael J. Parnham, Jochen Maas, & Gerd Geißlinger. (2019). 4 Ds in health research—working together toward rapid precision medicine. EMBO Molecular Medicine. 11(11). e10917–e10917. 8 indexed citations

Vogel, Hannes, Dieter Mayer, Franz J. Hock, & Jochen Maas. (2013). Drug Discovery and Evaluation: Safety and Pharmacokinetic Assays. Digital Access to Libraries (Université catholique de Louvain (UCL), l'Université de Namur (UNamur) and the Université Saint-Louis (USL-B)). 77 indexed citations

Maas, Jochen. (2012). New approaches in research and development of anti-diabetic drugs: an industry perspective. SHILAP Revista de lepidopterología. 3(4). 109–112. 4 indexed citations

Gebauer, Alexander, et al.. (2010). Drug Discovery and Evaluation: Methods in Clinical Pharmacology. Digital Access to Libraries (Université catholique de Louvain (UCL), l'Université de Namur (UNamur) and the Université Saint-Louis (USL-B)). 36 indexed citations

Maas, Jochen. (2007). Jackknife stability of a tractor semi-trailer combination. Data Archiving and Networked Services (DANS). 4 indexed citations

Maas, Jochen, et al.. (2006). An integrated early formulation strategy – From hit evaluation to preclinical candidate profiling. European Journal of Pharmaceutics and Biopharmaceutics. 66(1). 1–10. 44 indexed citations

Hinder, Markus, Annke Frick, Gary W. Hesse, et al.. (2006). Direct and rapid inhibition of factor Xa by otamixaban: A pharmacokinetic and pharmacodynamic investigation in patients with coronary artery disease. Clinical Pharmacology & Therapeutics. 80(6). 691–702. 17 indexed citations

Thomsen, Morten B., Avram Oros, Marja Schoenmakers, et al.. (2006). Proarrhythmic electrical remodelling is associated with increased beat-to-beat variability of repolarisation. Cardiovascular Research. 73(3). 521–530. 68 indexed citations

10.

Vogel, Hannes, Franz J. Hock, Jochen Maas, & Dieter Mayer. (2006). Drug Discovery and Evaluation. DIAL (Catholic University of Leuven). 34 indexed citations

11.

Gebhardt, Rolf, Jan G. Hengstler, D. Müller, et al.. (2003). New Hepatocyte In Vitro Systems for Drug Metabolism: Metabolic Capacity and Recommendations for Application in Basic Research and Drug Development, Standard Operation Procedures. Drug Metabolism Reviews. 35(2-3). 145–213. 200 indexed citations

12.

Herling, Andreas W., Dietmar Schwab, Hans-Joerg Burger, et al.. (2002). Prolonged blood glucose reduction in mrp-2 deficient rats (GY/TR−) by the glucose-6-phosphate translocase inhibitor S 3025. Biochimica et Biophysica Acta (BBA) - General Subjects. 1569(1-3). 105–110. 10 indexed citations

13.

Mertsch, Katharina & Jochen Maas. (2002). Blood-Brain Barrier Penetration and Drug Development from an Industrial Point of View. 2(3). 187–201. 23 indexed citations

14.

Steinke, Wolfram, Michael Becka, Rudolf Binder, et al.. (2000). Quantitative Distribution Studies in Animals: Cross-Validation of Radioluminography versus Liquid-Scintillation Measurement. Regulatory Toxicology and Pharmacology. 31(2). S33–S43. 20 indexed citations

15.

Maas, Jochen, Rudolf Binder, & Wolfram Steinke. (2000). Quantitative Whole-Body Autoradiography: Recommendations for the Standardization of the Method. Regulatory Toxicology and Pharmacology. 31(2). S15–S21. 13 indexed citations

16.

Adams, Julian, Vito J. Palombella, Edward A. Sausville, et al.. (1999). Proteasome inhibitors: a novel class of potent and effective antitumor agents.. PubMed. 59(11). 2615–22. 1188 indexed citations breakdown →

17.

Löbenberg, Raimar, Jochen Maas, & J. Kreuter. (1998). Improved Body Distribution of¹⁴C-labelled AZT bound to Nanoparticles in Rats determined by Radioluminography. Journal of drug targeting. 5(3). 171–179. 27 indexed citations

18.

Friedhoff, Arnold J., D. Pickar, Ian Creese, et al.. (1988). Neurochemistry and Neuropharmacology. Schizophrenia Bulletin. 14(3). 399–412. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact